SCHEMBL7866047

SCHEMBL7866047

CCCCC[C@@H](C=C[C@@H]1[C@@H](CC=CCCCC(=O)O)[C@@H](O[Si](C)(C)CC)C[C@H]1O[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE4D Q08499 4/20 0.51
TBXA2R P21731 6/20 0.49
LMNA P02545 4/20 0.49
ALDH1A1 P00352 4/20 0.49
PTGFR P43088 3/20 0.49
SLCO2A1 Q92959 2/20 0.49
PTGER1 P34995 2/20 0.49
PTGER3 P43115 2/20 0.49
PTGER4 P35408 1/20 0.49
PTGDR Q13258 1/20 0.49
HPGD P15428 2/20 0.46
ABCC4 O15439 1/20 0.46
TSHR P16473 1/20 0.46
MAPK1 P28482 1/20 0.46
HIF1A Q16665 1/20 0.46
KDM4E B2RXH2 1/20 0.44
HKDC1 Q2TB90 1/20 0.44
TDP1 Q9NUW8 1/20 0.44
SAE1 Q9UBE0 1/20 0.44
UBA2 Q9UBT2 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7666557 1.00 PDE4D (0.51) PDE4DTBXA2RLMNAALDH1A1PTGFR
SCHEMBL7666551 1.00 PDE4D (0.51) PDE4DTBXA2RLMNAALDH1A1PTGFR
SCHEMBL7671311 0.90 PDE4D (0.62) PDE4DTBXA2RLMNAALDH1A1PTGFR
SCHEMBL7671306 0.90 PDE4D (0.62) PDE4DTBXA2RLMNAALDH1A1PTGFR
SCHEMBL7671298 0.90 PDE4D (0.62) PDE4DTBXA2RLMNAALDH1A1PTGFR
SCHEMBL20740218 0.90 TBXA2R (0.60) PDE4DTBXA2RLMNAALDH1A1PTGFR
SCHEMBL20749914 0.90 TBXA2R (0.60) PDE4DTBXA2RLMNAALDH1A1PTGFR
SCHEMBL20740219 0.90 TBXA2R (0.60) PDE4DTBXA2RLMNAALDH1A1PTGFR
SCHEMBL7673833 0.90 PDE4D (0.53) PDE4DTBXA2RLMNAALDH1A1PTGFR
SCHEMBL7673838 0.90 PDE4D (0.53) PDE4DTBXA2RLMNAALDH1A1PTGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6307092-B1 POTENT OCULAR HYPOTENSIVES AND ARE PARTICULARLY SUITED FOR THE MANAGEMENT OF GLAUCOMA. ALLERGAN SALES, INC. 2001-10-23 US disclosed
US-6248783-B1 GLAUCOMA THERAPY ALLERGAN SALES, INC. 2001-06-19 US disclosed